ARDX
Ardelyx, Inc. · Healthcare
Chief Development Officer David P. Rosenbaum sold $199K of Ardelyx, Inc.
Sold$199,200
$6.64Price
30,000Shares
−6%Stake
What ARDX did after the filing
- The stock from Wed, Jan 10 close, $9.08
- −4.4%
- S&P 500, same days
- +6.6%
Measured over 30 trading days, to the Feb 23 close.
Traded Mon, Jan 8. Filed Wed, Jan 10, 12:36 PM ET, during the session. Returns use the Jan 10 close and the Feb 23 close. Not investment advice.